Litigation Note: Corin Wins Summary Judgment
Firm News | 1 min read | 02.04.16
Washington, D.C. – February 4, 2016: Crowell & Moring LLP is pleased to announce that clients Corin Group PLC and Corin USA Limited (collectively "Corin") have prevailed in a lawsuit alleging injuries from Corin’s hip resurfacing system, the Cormet, a Class III medical device approved by the U.S. Food and Drug Administration (Swisher v. Stryker Corporation, et al.). After full discovery, Crowell & Moring, on behalf of Corin, filed motions for summary judgment and to exclude the plaintiff’s sole liability expert, metallurgist Mr. Charles Powell. The U.S. District Court for the Western District of Oklahoma excluded the relevant opinions of Mr. Powell and granted summary judgment in favor of Corin on all claims, holding that there was no evidence of the purported defect in the device nor any evidence of medical causation for the plaintiff’s alleged injuries.
Crowell & Moring served as lead counsel to Corin in this matter.
Insights
Firm News | 2 min read | 05.22.26
May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).
Firm News | 2 min read | 05.20.26
Crowell Secures $23.3 Million Jury Verdict for C3.ai in Major Trade Secret Case
Firm News | 2 min read | 05.20.26
The Daily Journal Names Valerie Goo and Jon Gurka Among Top IP Lawyers
Firm News | 1 min read | 05.18.26
Los Angeles Business Journal Names Jennie Wang VonCannon to the 2026 Women of Influence: Attorneys
